Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of the International Society of Sports Nutrition
Published in: Journal of the International Society of Sports Nutrition 2/2005

Open Access 01-12-2005 | Review

Obesity: Prevalence, Theories, Medical Consequences, Management, and Research Directions

Authors: Colin Wilborn, Jacqueline Beckham, Bill Campbell, Travis Harvey, Melyn Galbreath, Paul La Bounty, Erika Nassar, Jennifer Wismann, Richard Kreider

Published in: Journal of the International Society of Sports Nutrition | Issue 2/2005

Login to get access

Abstract

Obesity and its associated disorders are a growing epidemic across the world. Many genetic, physiological, and behavioral factors play a role in the etiology of obesity. Diet and exercise are known to play a valuable role in the treatment and prevention of obesity and associated disorders such as hypertension, heart disease, and diabetes. Therefore, the purpose of this review is to examine the prevalence, etiology, consequences, and treatment of obesity.
Literature
1.
Bray GaBC: Handbook of Obesity: Etiology and Pathophysiology. 2004, Marcel Dekker Inc, 1200-2
2.
Deurenberg P, Yap M: The assessment of obesity: methods for measuring body fat and global prevalence of obesity. Baillieres Best Pract Res Clin Endocrinol Metab. 1999, 13 (1): 1–11. 10.1053/beem.1999.0003.PubMed
3.
Weisell RC: Body mass index as an indicator of obesity. Asia Pac J Clin Nutr. 2002, 11 (Suppl 8): S681–4. 10.1046/j.1440-6047.11.s8.5.x.
4.
Gregg EW, Cheng YJ, Cadwell BL: Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005, 293 (15): 1868–74. 10.1001/jama.293.15.1868.PubMed
5.
Freedman DS, Khan LK, Serdula MK: Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA. 2002, 288 (14): 1758–61. 10.1001/jama.288.14.1758.PubMed
6.
Ogden CL, Flegal KM, Carroll MD: Prevalence and trends in overweight among US children and adolescents, 1999–2000. JAMA. 288 (14): 1728–32. 10.1001/jama.288.14.1728. 2002 Oct 9; 2002. 288(14): p. 1728–32.PubMed
7.
Seidell JC, Flegal KM: Assessing obesity: classification and epidemiology. Br Med Bull. 1997, 53 (2): 238–52.PubMed
8.
Cockram CS: The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J. 2000, 6 (1): 43–52.PubMed
9.
Gill TP: Cardiovascular risk in the Asia-Pacific region from a nutrition and metabolic point of view: abdominal obesity. Asia Pac J Clin Nutr. 2001, 10 (2): 85–9. 10.1046/j.1440-6047.2001.00231.x.PubMed
10.
Heshka SAJ, Atkinson RL, Greenway FL, Hill JO, Phinney SD, Kolotkin RL, Miller-Kovach K, Pi-Sunyer FX: Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA. 2003, 289: 1792–1798. 10.1001/jama.289.14.1792.PubMed
11.
Colditz GA: Economic costs of obesity and inactivity. Med Sci Sports Exerc. 1999, 31 (11 Suppl): S663–7.PubMed
12.
Finkelstein EA, Ruhm CJ, Kosa KM: Economic causes and consequences of obesity. Annu Rev Public Health. 2005, 26: 239–57. 10.1146/annurev.publhealth.26.021304.144628.PubMed
13.
Quesenberry CP, Caan B, Jacobson A: Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med. 1998, 158 (5): 466–72. 10.1001/archinte.158.5.466.PubMed
14.
Thompson D, Brown JB, Nichols GA: Body mass index and future healthcare costs: a retrospective cohort study. Obes Res. 2001, 9 (3): 210–8.PubMed
15.
Finkelstein EA, Fiebelkorn IC, Wang G: National medical spending attributable to overweight and obesity: how much, and who's paying?. Health Aff (Millwood). 2003, W3-219-26-Suppl Web Exclusives
16.
17.
Murphy C, Yates J: Economic comparison of weight loss programmes versus drug treatment for the management of obesity. Asia Pac J Clin Nutr. 2005, 14 (Suppl): S97–S105.
18.
Manson JE, Stampfer MJ, Hennekens CH: Body weight and longevity:a reassessment. JAMA. 1987, 257: 353–358. 10.1001/jama.257.3.353.PubMed
19.
Andres R, Muller DC, Sorkin JD: Long-term effects of change in body weight on all-cause mortality. A review. Annals of Internal Medicine. 1993, 110: 737–743.
20.
Stevens J: Impact of age on associations between weight and mortality. Nutr Rev. 2000, 58: 129–137.PubMed
21.
Stevens J, Cai J, Pamuk ER: The effects of age on the association between body mass index and mortality. New England Journal of Medicine. 1998, 338: 1–7. 10.1056/NEJM199801013380101.
22.
Jequier E, Tappy L: Regulation of body weight in humans. Physiol Rev. 1999, 79 (2): 451–80.PubMed
23.
Spiegelman BM, Flier JS: Obesity and the regulation of energy balance. Cell. 2001, 104 (4): 531–43. 10.1016/S0092-8674(01)00240-9.PubMed
24.
Flatt JP, Ravussin E, Acheson KJ: Effects of dietary fat on postprandial substrate oxidation and on carbohydrate and fat balances. J Clin Invest. 1985, 76 (3): 1019–24.PubMedPubMedCentral
25.
Schutz Y, Flatt JP, Jequier E: Failure of dietary fat intake to promote fat oxidation: a factor favoring the development of obesity. Am J Clin Nutr. 1989, 50 (2): 307–14.PubMed
26.
Jequier E: Nutrient effects: post-absorptive interactions. Proc Nutr Soc. 1995, 54 (1): 253–65. 10.1079/PNS19950052.PubMed
27.
Labayen I, Diez N, Gonzalez A: Effects of protein vs. carbohydrate-rich diets on fuel utilisation in obese women during weight loss. Forum Nutr. 2003, 56: 168–70.PubMed
28.
Skov AR, Toubro S, Ronn B: Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord. 1999, 23 (5): 528–36. 10.1038/sj.ijo.0800867.PubMed
29.
Baba NH, Sawaya S, Torbay N: High protein vs high carbohydrate hypoenergetic diet for the treatment of obese hyperinsulinemic subjects. Int J Obes Relat Metab Disord. 1999, 23 (11): 1202–6. 10.1038/sj.ijo.0801064.PubMed
30.
Farnsworth E, Luscombe ND, Noakes M: Effect of a high-protein, energy-restricted diet on body composition, glycemic control, and lipid concentrations in overweight and obese hyperinsulinemic men and women. Am J Clin Nutr. 2003, 78 (1): 31–9.PubMed
31.
Noakes M, Keogh JB, Foster PR: Effect of an energy-restricted, high-protein, low-fat diet relative to a conventional high-carbohydrate, low-fat diet on weight loss, body composition, nutritional status, and markers of cardiovascular health in obese women. Am J Clin Nutr. 2005, 81 (6): 1298–306.PubMed
32.
Brinkworth GD, Noakes M, Keogh JB: Long-term effects of a high-protein, low-carbohydrate diet on weight control and cardiovascular risk markers in obese hyperinsulinemic subjects. Int J Obes Relat Metab Disord. 2004, 28 (5): 661–70. 10.1038/sj.ijo.0802617.PubMed
33.
Luscombe ND, Clifton PM, Noakes M: Effect of a high-protein, energy-restricted diet on weight loss and energy expenditure after weight stabilization in hyperinsulinemic subjects. Int J Obes Relat Metab Disord. 2003, 27 (5): 582–90. 10.1038/sj.ijo.0802270.PubMed
34.
St-Onge MP, Ross R, Parsons WD: Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res. 2003, 11 (3): 395–402.PubMed
35.
Ello-Martin JA, Ledikwe JH, Rolls BJ: The influence of food portion size and energy density on energy intake: implications for weight management. Am J Clin Nutr. 2005, 82 (1 Suppl): 236S–241S.PubMed
36.
Rolls BJ, Ello-Martin JA, Tohill BC: What can intervention studies tell us about the relationship between fruit and vegetable consumption and weight management?. Nutr Rev. 2004, 62 (1): 1–17. 10.1301/nr.2004.jan.1-17.PubMed
37.
Tohill BC, Seymour J, Serdula M: What epidemiologic studies tell us about the relationship between fruit and vegetable consumption and body weight. Nutr Rev. 2004, 62 (10): 365–74. 10.1301/nr.2004.oct.365-374.PubMed
38.
Epstein LH, Gordy CC, Raynor HA: Increasing fruit and vegetable intake and decreasing fat and sugar intake in families at risk for childhood obesity. Obes Res. 2001, 9 (3): 171–8.PubMed
39.
Viguerie N, Vidal H, Arner P: Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia. 2005, 48 (1): 123–31. 10.1007/s00125-004-1618-x.PubMed
40.
Bastard JP, Hainque B, Dusserre E: Peroxisome proliferator activated receptor-gamma, leptin and tumor necrosis factor-alpha mRNA expression during very low calorie diet in subcutaneous adipose tissue in obese women. Diabetes Metab Res Rev. 1999, 15 (2): 92–8. 10.1002/(SICI)1520-7560(199903/04)15:2<92::AID-DMRR21>3.0.CO;2-4.PubMed
41.
Faith MS, Rha SS, Neale MC: Evidence for genetic influences on human energy intake: results from a twin study using measured observations. Behav Genet. 1999, 29 (3): 145–54. 10.1023/A:1021683716700.PubMed
42.
Levine JA, Kotz CM: NEAT – non-exercise activity thermogenesis – egocentric & geocentric environmental factors vs. biological regulation. Acta Physiol Scand. 2005, 184 (4): 309–18. 10.1111/j.1365-201X.2005.01467.x.PubMed
43.
Hill O, Saris W, Levine J: The Handbook of Obesity: Etiology and Pathophysiology. Edited by: Bouchard GABaC. 2004, New York: Marcel Dekker Inc, Second
44.
Dauncey MJ: Activity and energy expenditure. Can J Physiol Pharmacol. 1990, 68 (1): 17–27.PubMed
45.
Castaneda TR, Jurgens H, Wiedmer P: Obesity and the neuroendocrine control of energy homeostasis: the role of spontaneous locomotor activity. J Nutr. 2005, 135 (5): 1314–9.PubMed
46.
DiPietro L: Physical activity, body weight, and adiposity: an epidemiologic perspective. Exerc Sport Sci Rev. 1995, 23: 275–303. 10.1249/00003677-199500230-00011.PubMed
47.
Meredith CN, Zackin MJ, Frontera WR: Body composition and aerobic capacity in young and middle-aged endurance-trained men. Med Sci Sports Exerc. 1987, 19 (6): 557–63.PubMed
48.
Ballor DL, Keesey RE: A meta-analysis of the factors affecting exercise-induced changes in body mass, fat mass and fat-free mass in males and females. Int J Obes. 1991, 15 (11): 717–26.PubMed
49.
Slentz CA, Aiken LB, Houmard JA: Inactivity, exercise and visceral fat. STRRIDE: a randomized, controlled study of exercise intensity and amount. J Appl Physiol. 2005
50.
Williams PT, Blanche PJ, Krauss RM: Behavioral versus genetic correlates of lipoproteins and adiposity in identical twins discordant for exercise. Circulation. 2005, 112 (3): 350–6. 10.1161/CIRCULATIONAHA.105.534578.PubMed
51.
Giorgino F, Laviola L, Eriksson JW: Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand. 2005, 183 (1): 13–30. 10.1111/j.1365-201X.2004.01385.x.PubMed
52.
Rorive M, Letiexhe MR, Scheen AJ: [Obesity and type 2 diabetes]. Rev Med Liege. 2005, 60 (5–6): 374–82.PubMed
53.
Pinkney J, Kopelman P, eds: Handbook of Obesity: Etiology and Pathophysiology. Edited by: Bouchard GABaC. 2004, Marcel Dekker, Inc: New York, 1046-Second
54.
Lafontan M: Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol. 2005, 45: 119–46. 10.1146/annurev.pharmtox.45.120403.095843.PubMed
55.
Cases JA, Gabriely I, Ma XH: Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes. 2001, 50 (2): 348–52. 10.2337/diabetes.50.2.348.PubMed
56.
Schwartz MW, Woods SC, Porte D: Central nervous system control of food intake. Nature. 2000, 404 (6778): 661–71.PubMed
57.
Banks AS, Davis SM, Bates SH: Activation of downstream signals by the long form of the leptin receptor. J Biol Chem. 2000, 275 (19): 14563–72. 10.1074/jbc.275.19.14563.PubMed
58.
Considine RV, Considine EL, Williams CJ: The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes. 1996, 45 (7): 992–4. 10.2337/diabetes.45.7.992.PubMed
59.
Considine RV, Sinha MK, Heiman ML: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996, 334 (5): 292–5. 10.1056/NEJM199602013340503.PubMed
60.
Sahu A, Kalra S: Neuropeptidergic regulation of feeding behavior: Neuropeptide Y. Trends Endocrinol Metab. 1993, 4: 217–224. 10.1016/1043-2760(93)90125-X.PubMed
61.
Baranowska B, Wolinska-Witort E, Wasilewska-Dziubinska E: The role of neuropeptides in the disturbed control of appetite and hormone secretion in eating disorders. Neuro Endocrinol Lett. 2003, 24 (6): 431–4.PubMed
62.
Epel E, Lapidus R, McEwen B: Stress may add bite to appetite in women: a laboratory study of stress-induced cortisol and eating behavior. Psychoneuroendocrinology. 2001, 26 (1): 37–49. 10.1016/S0306-4530(00)00035-4.PubMed
63.
Bjorntorp P, Rosmond R: Obesity and cortisol. Nutrition. 2000, 16 (10): 924–36. 10.1016/S0899-9007(00)00422-6.PubMed
64.
Drapeau V, Therrien F, Richard D: Is visceral obesity a physiological adaptation to stress?. Panminerva Med. 2003, 45 (3): 189–95.PubMed
65.
Dallman MF, la Fleur SE, Pecoraro NC: Minireview: glucocorticoids – food intake, abdominal obesity, and wealthy nations in 2004. Endocrinology. 2004, 145 (6): 2633–8. 10.1210/en.2004-0037.PubMed
66.
Cummings DE, Purnell JQ, Frayo RS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001, 50 (8): 1714–9. 10.2337/diabetes.50.8.1714.PubMed
67.
Shintani M, Ogawa Y, Ebihara K: Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 2001, 50 (2): 227–32. 10.2337/diabetes.50.2.227.PubMed
68.
Bray GA: Contemporary Diagnosis and Management of Obesity and The Metabolic Syndrome. 2003, Newtown, Pennsylvania: Handbooks in Health Care, Co, 328-Third
69.
Vgontzas AN, Papanicolaou DA, Bixler EO: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab. 1997, 82 (5): 1313–6. 10.1210/jc.82.5.1313.PubMed
70.
Trujillo ME, Sullivan S, Harten I: Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab. 2004, 89 (11): 5577–82. 10.1210/jc.2004-0603.PubMed
71.
Pasquali R, Vicennati V, Pagotto U, eds: Handbook of Obesity: Etiology and Pathophysiology. Edited by: Bouchard GABaC. 2004, Marcel Dekker: New York, 1046-second
72.
Aycan Z, Berberoglu M, Ocal G: Relationship between plasma leptin, insulin and tumor necrosis factor alpha in obese children. J Pediatr Endocrinol Metab. 2005, 18 (3): 275–84.PubMed
73.
Schoemaker RC, Buijs MM, Pijl H: Modeling the influence of growth hormone on lipolysis. J Pharmacokinet Pharmacodyn. 2002, 29 (2): 157–70. 10.1023/A:1019803924485.PubMed
74.
Hansen TK: Pharmacokinetics and acute lipolytic actions of growth hormone. Impact of age, body composition, binding proteins, and other hormones. Growth Horm IGF Res. 2002, 12 (5): 342–58. 10.1016/S1096-6374(02)00061-8.PubMed
75.
Iacobellis G, Ribaudo MC, Zappaterreno A: Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf). 2005, 62 (4): 487–91. 10.1111/j.1365-2265.2005.02247.x.
76.
Koppeschaar HP, Meinders AE, Schwarz F: Metabolic responses in grossly obese subjects treated with a very-low-calorie diet with and without triiodothyronine treatment. Int J Obes. 1983, 7 (2): 133–41.PubMed
77.
Bray G: Commentary on Banting letters. Obes Res. 1993, 1: 148–152.PubMed
78.
Huszar D, Lynch CA, Fairchild-Huntress V: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997, 88 (1): 131–41. 10.1016/S0092-8674(00)81865-6.PubMed
79.
Bray GA, Greenway FL: Current and potential drugs for treatment of obesity. Endocr Rev. 1999, 20 (6): 805–75. 10.1210/er.20.6.805.PubMed
80.
Brennan IM, Feltrin KL, Horowitz M: Evaluation of interactions between CCK and GLP-1 in their effects on appetite, energy intake, and antropyloroduodenal motility in healthy men. Am J Physiol Regul Integr Comp Physiol. 2005, 288 (6): R1477–85.PubMed
81.
Bjorntorp P: Body fat distribution, insulin resistance, and metabolic diseases. Nutrition. 1997, 13 (9): 795–803. 10.1016/S0899-9007(97)00191-3.PubMed
82.
Oren S, Grossman E, Frohlich ED: Arterial and venous compliance in obese and nonobese subjects. Am J Cardiol. 1996, 77 (8): 665–7. 10.1016/S0002-9149(97)89331-9.PubMed
83.
Rauch U, Osende JI, Fuster V: Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med. 2001, 134 (3): 224–38.PubMed
84.
Booth FW: Pieces of the Same Human Puzzle: Evolution, Physical Activity, Chronic Disease, Public Health and Policy. 2005, American College of Sports Medicine. Nashville, TN
85.
Pearson TA, Derby CA: Invited commentary: should arteriographic case-control studies be used to identify causes of atherosclerotic coronary artery disease?. Am J Epidemiol. 1991, 134 (2): 123–8.PubMed
86.
Clark LT, Karve MM, Rones KT: Obesity, distribution of body fat and coronary artery disease in black women. Am J Cardiol. 1994, 73 (12): 895–6. 10.1016/0002-9149(94)90818-4.PubMed
87.
Rexrode KM, Carey VJ, Hennekens CH: Abdominal adiposity and coronary heart disease in women. Jama. 1998, 280 (21): 1843–8. 10.1001/jama.280.21.1843.PubMed
88.
Hubert HB, Feinleib M, McNamara PM: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983, 67 (5): 968–77.PubMed
89.
Stamler R, Stamler J, Riedlinger WF: Weight and blood pressure. Findings in hypertension screening of 1 million Americans. Jama. 1978, 240 (15): 1607–10. 10.1001/jama.240.15.1607.PubMed
90.
Landsberg L: Obesity and hypertension: experimental data. J Hypertens Suppl. 1992, 10 (7): S195–201. 10.1097/00004872-199212007-00022.PubMed
91.
Meehan WP, Darwin CH, Maalouf NB: Insulin and hypertension: are they related?. Steroids. 1993, 58 (12): 621–34. 10.1016/0039-128X(93)90105-V.PubMed
92.
Rocchini AP, Moorehead C, DeRemer S: Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II. Hypertension. 1990, 15 (6 Pt 2): 861–6.PubMed
93.
Krief S, Lonnqvist F, Raimbault S: Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest. 1993, 91 (1): 344–9.PubMedPubMedCentral
94.
Anderson EA, Hoffman RP, Balon TW: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991, 87 (6): 2246–52.PubMedPubMedCentral
95.
Wu HY, Jeng YY, Yue CJ: Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring. Diabetes. 1994, 43 (8): 1027–32. 10.2337/diabetes.43.8.1027.PubMed
96.
Collins S, Kuhn CM, Petro AE: Role of leptin in fat regulation. Nature. 1996, 380 (6576): 677–10.1038/380677a0.PubMed
97.
Golden PL, Maccagnan TJ, Pardridge WM: Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest. 1997, 99 (1): 14–8.PubMedPubMedCentral
98.
Letiexhe MR, Scheen AJ, Gerard PL: Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects. Int J Obes Relat Metab Disord. 1994, 18 (5): 295–300.PubMed
99.
Mavri A, Stegnar M, Sentocnik JT: Impact of weight reduction on early carotid atherosclerosis in obese premenopausal women. Obes Res. 2001, 9 (9): 511–6.PubMed
100.
Giltay EJ, Lambert J, Elbers JM: Arterial compliance and distensibility are modulated by body composition in both men and women but by insulin sensitivity only in women. Diabetologia. 1999, 42 (2): 214–21. 10.1007/s001250051141.PubMed
101.
Chi MM, Hintz CS, Henriksson J: Chronic stimulation of mammalian muscle: enzyme changes in individual fibers. Am J Physiol. 1986, 251 (4 Pt 1): C633–42.PubMed
102.
Messerli FH, Nunez BD, Ventura HO: Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity. Arch Intern Med. 1987, 147 (10): 1725–8. 10.1001/archinte.147.10.1725.PubMed
103.
Zemva A, Zemva Z: Ventricular ectopic activity, left ventricular mass, hyperinsulinemia, and intracellular magnesium in normotensive patients with obesity. Angiology. 2000, 51 (2): 101–6.PubMed
104.
Lapidus L, Bengtsson C, Larsson B: Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed). 1984, 289 (6454): 1257–61.
105.
Ness J, Aronow WS, Ahn C: Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 2000, 48 (3): 312–4.PubMed
106.
Plavnik FL, Ajzen S, Kohlmann O: Intima-media thickness evaluation by B-mode ultrasound. Correlation with blood pressure levels and cardiac structures. Braz J Med Biol Res. 2000, 33 (1): 55–64. 10.1590/S0100-879X2000000100008.PubMed
107.
Kannel WB, Plehn JF, Cupples LA: Cardiac failure and sudden death in the Framingham Study. Am Heart J. 1988, 115 (4): 869–75. 10.1016/0002-8703(88)90891-5.PubMed
108.
Association AH: Heart Disease and Stroke Statistics – 2005 Update. 2005, American Heart Association: Dallas
109.
Finer N, Bloom SR, Frost GS: Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study. Diabetes Obes Metab. 2000, 2 (2): 105–12. 10.1046/j.1463-1326.2000.00071.x.PubMed
110.
Hauner H: The impact of pharmacotherapy on weight management in type 2 diabetes. Int J Obes Relat Metab Disord. 1999, 23 (Suppl 7): S12–7. 10.1038/sj.ijo.0800956.PubMed
111.
Williams KV, Mullen ML, Kelley DE: The effect of short periods of caloric restriction on weight loss and glycemic control in type 2 diabetes. Diabetes Care. 1998, 21 (1): 2–8. 10.2337/diacare.21.1.2.PubMed
112.
Duggirala R, Mitchell BD, Blangero J: Genetics determinants of variation in gallbladder disease in the Mexican-American population. Genetic Epidemiology. 1999, 16 (2): 191–204. 10.1002/(SICI)1098-2272(1999)16:2<191::AID-GEPI6>3.0.CO;2-6.PubMed
113.
Acalovschi M, Blendea D: Risk of asymptomatic and symptomatic gallstones in moderately obesewomen: a longitudineal follow-up study. American Journal of Gastroenterology. 1997, 92 (1): 127–131.
114.
Kono S, Kochi S: Gallstones, serum lipids, and glucose tolerance among male officials of self-defense forces in Japan. Dig Dis Sci. 1988, 33 (7): 839–834. 10.1007/BF01550973.PubMed
115.
Dittrick D, Thompson J: Gallbladder pathology in obesity. Obesity. 2005, 15 (2): 238–242. 10.1381/0960892053268273.
116.
Sauter GH, Thiessen K, Parhofer KG: Effects of ursodeoxycholic acid on cholesterol and bile acids in healthy subjects. Digestion. 2004, 70 (2): 79–83. 10.1159/000080925.PubMed
117.
Christensen R, Astrup A, Bliddal H: Weight loss: the treatment of choice for knee osteoarthritis? A randomized trial. Ostearthritis Cartilage. 2005, 13 (1): 20–7. 10.1016/j.joca.2004.10.008.
118.
Holmberg S, Thelin N: Knee osteoarthritis and body mass index: a population based case control study. Scand J Rheumatology. 2005, 34 (1): 59–64. 10.1080/03009740510017922.
119.
Linne Y, Dye L, Barkeling B: Weight development over time in parous women-the SPAWN study-15 years follow up. Int J Obes Relat Metab Disorders. 2003, 27 (12): 1516–22. 10.1038/sj.ijo.0802441.
120.
Phillips DIW, Bennett FI, Wilks R: Maternal body composition, offspring blood pressure and the hypothalmic-pituitary-adrenal axis. Pediatric and Perinatal Epidemiology. 2005, 19 (4): 294–299. 10.1111/j.1365-3016.2005.00661.x.PubMed
121.
Strohl KP, Redline S: Recognition of obstructive sleep apnea. Ear Nose Throat. 1996, 154 (2): 279–289.
122.
Peppard PE, Young T, Palta M: Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000, 284 (23): 3015–3021. 10.1001/jama.284.23.3015.PubMed
123.
Strollo PJ, Rogers RM: Ostructive sleep apnea. New England Journal of Medicine. 1996, 334 (2): 99–104. 10.1056/NEJM199601113340207.
124.
Speigel K, Leproult R, L'Hermite-Baleriaux M: Leptin Levels are Dependent on Sleep Duration: Relationships with Sympathovagal Balance, Carbohydrate Regulation, Cortisol, and Thyrotropin. The Journal of Clinical Endocrinology and Metabolism. 2004, 89 (11): 5762–5771. 10.1210/jc.2004-1003.
125.
Piechota G, Malkiewiez J, Karwar ID: Obesity as a cause and result of disability. Prezegl Epidemiology. 2005, 59 (155–161):
126.
Poves PI, Macias GJ, Cebrara FMea: Quality of life in morbid obesity. Rev ESp Enferm Digest. 2005, 97 (3): 187–195.
127.
Daniels SR: Regulation of body mass and management of childhood overweight. Pediatr Blood Cancer. 2005, 44 (7): 589–94. 10.1002/pbc.20353.PubMed
128.
Williams AE, DB : A commercial weight-reducing organization: a critical analysis. Med J Aust. 1976, 1: 781–785.PubMed
129.
Blackburn GL, Waltman BA: Expanding the limits of treatment – new strategic initiatives. J Am Diet Assoc. 2005, 105 (5 Suppl 1): S131–5. 10.1016/j.jada.2005.02.019.PubMed
130.
Riebe D, Greene GW, Ruggiero L: Evaluation of a healthy-lifestyle approach to weight management. Prev Med. 2003, 36 (1): 45–54. 10.1006/pmed.2002.1126.PubMed
131.
Wisotsky W, Swencionis C: Cognitive-behavioral approaches in the management of obesity. Adolesc Med. 2003, 14 (1): 37–48.PubMed
132.
Poston WS, Haddock CK, Dill PL, Thayer B, Foreyt JP: Lifestyle treatments in randomized clinical trials of pharmacotherapies for obesity. Obes Res. 2001, 9 (9): 552–563.PubMed
133.
Tsui AGaW, Thomas A: Systematic Review: An Evaluation of Major Commercial Weight Loss Programs in the United States. Annals of Internal Medicine. 2005, 142 (1): 56–66.
134.
Lowe MR, M-KK , Phelan S: Weight-loss maintenance in overweight individuals one to five years following successful completion of a commercial weight loss program. Int J Obes Relat Metab Disord. 2001, 25: 325–331. 10.1038/sj.ijo.0801521.PubMed
135.
Heshka SGF, Anderson JW, Atkinson RL, Hill JO, Phinney SD, Miller-Kovach K, Pi-Sunyer FX: Self-help weight loss versus a structured commercial program after 26 weeks: a randomized controlled study. Am J Med. 2000, 109: 282–287. 10.1016/S0002-9343(00)00494-0.PubMed
136.
Hamilton M, Greenway F: Evaluating commercial weight loss programmes: an evolution in outcomes research. Obes Rev. 2004, 5 (4): 217–32. 10.1111/j.1467-789X.2004.00153.x.PubMed
137.
Wolfe BL: Long-term maintenance following attainment of goal weight: a preliminary investigation. Addict Behav. 1992, 17 (5): 469–77. 10.1016/0306-4603(92)90007-I.PubMed
138.
Atkins R: Dr Atkins' diet revolution: The high calorie way to stay thin forever. 1972, New York: David McKay, Inc
139.
Westman EC, Yancy WS, Edman JS: Effect of 6-month adherence to a very low carbohydrate diet program. Am J Med. 2002, 113 (1): 30–6. 10.1016/S0002-9343(02)01129-4.PubMed
140.
Volek J, Sharman MJ, Gómez AL, Judelson DA, Rubin MR, Watson G, Sokmen B, Silvestre R, French DN, Kraemer WJ: Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women. Nutr Metab (Lond). 2004, 1 (13):
141.
Willi SM, Oexmann , Mary Joan, Wright , Nancy M, Collop , Nancy A, Key L, Lyndon : The Effects of a High-protein, Low-fat, Ketogenic Diet on Adolescents With Morbid Obesity: Body Composition, Blood Chemistries, and Sleep Abnormalities. Pediatrics. 1998, 101 (1): 61–67. 10.1542/peds.101.1.61.PubMed
142.
Slavin JL: Dietary fiber and body weight. Nutrition. 2004, 21 (3): 411–418. 10.1016/j.nut.2004.08.018.
143.
Warren J, Henry JCea: Low glycemic index breakfasts and reduced food intake in preadolescent children. Pediatrics. 2003, 112: e414-10.1542/peds.112.5.e414.PubMed
144.
Kappagoda C, Hyson : Low-carbohydrate-high-protein diets: is there a place for them in clinical cardiology?". Journal of the American College of Cardiology. 2003, 43 (5): 725–730. 10.1016/j.jacc.2003.06.022.
145.
Roberts D: Quick weight loss: sorting fad from fact. The Medical Journal of Australia. 2001, 175: 637–640.PubMed
146.
Anderson JW, KE , Jenkins DJ: Health advantages and disadvantages of weight reducing diets: a computer analysis and critical review. The Journal of the American College of Nutrition. 2000, 19 (5): 578–590.PubMed
147.
McMillan-Price J, Brand-Miller J: Dietary approaches to overweight and obesity. Clin Dermatol. 2004, 22 (4): 310–4. 10.1016/j.clindermatol.2004.01.003.PubMed
148.
Bouche C, Rizkalla SW, Luo J: Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men. Diabetes Care. 2002, 25 (5): 822–8. 10.2337/diacare.25.5.822.PubMed
149.
Ebbeling CB, Leidig MM, Sinclair KB: A reduced-glycemic load diet in the treatment of adolescent obesity. Arch Pediatr Adolesc Med. 2003, 157 (8): 773–9. 10.1001/archpedi.157.8.773.PubMed
150.
Spieth LE, Harnish JD, Lenders CM: A low-glycemic index diet in the treatment of pediatric obesity. Arch Pediatr Adolesc Med. 2000, 154 (9): 947–51.PubMed
151.
Wechsler JG, Leopold K: Medical management of obesity. Langenbecks Arch Surg. 2003, 388 (6): 369–74.PubMed
152.
Fujioka K: Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obes Res. 2002, 10 (Suppl 2): 116S–123S.PubMed
153.
Wing RR, Marcus MD, Salata R: Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med. 1991, 151 (7): 1334–40. 10.1001/archinte.151.7.1334.PubMed
154.
Willi SM, Martin K, Datko FM: Treatment of type 2 diabetes in childhood using a very-low-calorie diet. Diabetes Care. 2004, 27 (2): 348–53. 10.2337/diacare.27.2.348.PubMed
155.
Armitage CJ: Can the Theory of Planned Behavior Predict the Maintenance of Physical Activity?. Health Psychology. 2005, 24 (3): 235–245. 10.1037/0278-6133.24.3.235.PubMed
156.
Epstein LHV, Alice Wing, Rena R, McCurley James: Ten-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychology. 1994, 13 (5): 373–383. 10.1037/0278-6133.13.5.373.PubMed
157.
Wilson GT: Behavioral treatment of childhood obesity: Theoretical and practical implications. Health Psychology. 1994, 13 (1): 371–372. 10.1037/0278-6133.13.5.371.PubMed
158.
Schmidt M, Affenito SG, Striegel-Moore R: Fast-food intake and diet quality in black and white girls: the National Heart, Lung, and Blood Institute Growth and Health Study. Arch Pediatr Adolesc Med. 2005, 159 (7): 626–31. 10.1001/archpedi.159.7.626.PubMed
159.
Affenito SG, Thompson DR, Barton BA: Breakfast consumption by African-American and white adolescent girls correlates positively with calcium and fiber intake and negatively with body mass index. J Am Diet Assoc. 2005, 105 (6): 938–45. 10.1016/j.jada.2005.03.003.PubMed
160.
Yanovski SZ, Bain RP, Williamson DF: Report of a National Institutes of Health-Centers for Disease Control and Prevention workshop on the feasibility of conducting a randomized clinical trial to estimate the long-term health effects of intentional weight loss in obese persons. Am J Clin Nutr. 1999, 69: 366–72.PubMed
161.
Reeves RS, McPherson RS, Nichaman MZ: Nutrient intake of obese female binge eaters. J Am Diet Assoc. 2001, 101 (2): 209–15. 10.1016/S0002-8223(01)00055-4.PubMed
162.
Yanovski SZ, Devlin MJ: Role of behavioral therapy in the management of obesity. Endocr Pract. 1995, 1 (5): 340–5.PubMed
163.
Dubnov G, Brzezinski A, Berry EM: Weight control and the management of obesity after menopause: the role of physical activity. Maturitas. 2003, 44 (2): 89–101. 10.1016/S0378-5122(02)00328-6.PubMed
164.
Deedwania PC, Volkova N: Current Treatment Options for the Metabolic Syndrome. Curr Treat Options Cardiovasc Med. 2005, 7 (1): 61–74. 10.1007/s11936-005-0007-1.PubMed
165.
Chanoine JP, Hampl S, Jensen C: Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. Jama. 2005, 293 (23): 2873–83. 10.1001/jama.293.23.2873.PubMed
166.
Boozer CN, Daly PA, Homel P: Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord. 2002, 26 (5): 593–604. 10.1038/sj.ijo.0802023.PubMed
167.
Boozer CN, Nasser JA, Heymsfield SB: An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord. 2001, 25 (3): 316–24. 10.1038/sj.ijo.0801539.PubMed
168.
Greenway FL, Ryan DH, Bray GA: Pharmaceutical cost savings of treating obesity with weight loss medications. Obes Res. 1999, 7 (6): 523–31.PubMed
169.
Molnar D, Torok K, Erhardt E: Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents. Int J Obes Relat Metab Disord. 2000, 24 (12): 1573–8. 10.1038/sj.ijo.0801433.PubMed
170.
Kreider R, Almada AL, Antonio J, Broeder C, Conrad E, Greenwood M, Incledon T, Kalman DS, Kleiner SM, Leutholtz B, Lowery LM, Mendel R, Stout JR, Willoughby DS, Ziegenfus TN: ISSN Exercise & Sport Nutrition Review: Research & Recommendations. Sports Nutrition Review Journal. 2004, 1 (1): 1–44.PubMedCentral
171.
Zemel MB: Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr. 2002, 21 (2): 146S–151S.PubMed
172.
Dulloo AG, Seydoux J, Girardier L: Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord. 2000, 24 (2): 252–8. 10.1038/sj.ijo.0801101.PubMed
173.
Shigematsu N, Asano R, Shimosaka M: Effect of administration with the extract of Gymnema sylvestre R. Br leaves on lipid metabolism in rats. Biol Pharm Bull. 2001, 24 (6): 713–7. 10.1248/bpb.24.713.PubMed
174.
Ishihara K, Oyaizu S, Onuki K: Chronic (-)-hydroxycitrate administration spares carbohydrate utilization and promotes lipid oxidation during exercise in mice. J Nutr. 2000, 130 (12): 2990–5.PubMed
175.
Kriketos AD, Thompson HR, Greene H: (-)-Hydroxycitric acid does not affect energy expenditure and substrate oxidation in adult males in a post-absorptive state. Int J Obes Relat Metab Disord. 1999, 23 (8): 867–73. 10.1038/sj.ijo.0800965.PubMed
176.
Pariza MW, Park Y, Cook ME: Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med. 2000, 223 (1): 8–13. 10.1046/j.1525-1373.2000.22302.x.PubMed
177.
Pariza MW, Park Y, Cook ME: The biologically active isomers of conjugated linoleic acid. Prog Lipid Res. 2001, 40 (4): 283–98. 10.1016/S0163-7827(01)00008-X.PubMed
178.
Zambell KL, Keim NL, Van Loan MD: Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids. 2000, 35 (7): 777–82. 10.1007/s11745-000-0585-z.PubMed
179.
Kreider RB, Ferreira MP, Greenwood M: Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res. 2002, 16 (3): 325–34. 10.1519/1533-4287(2002)016<0325:EOCLAS>2.0.CO;2.PubMed
180.
Hasten DL, Rome EP, Franks BD: Effects of chromium picolinate on beginning weight training students. Int J Sport Nutr. 1992, 2 (4): 343–50.PubMed
181.
Grant KE, Chandler RM, Castle AL: Chromium and exercise training: effect on obese women. Med Sci Sports Exerc. 1997, 29 (8): 992–8.PubMed
182.
Walker LS, Bemben MG, Bemben DA: Chromium picolinate effects on body composition and muscular performance in wrestlers. Med Sci Sports Exerc. 1998, 30 (12): 1730–7. 10.1097/00005768-199812000-00012.PubMed
183.
Lukaski HC, Bolonchuk WW, Siders WA: Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am J Clin Nutr. 1996, 63 (6): 954–65.PubMed
184.
Phelan S, Wadden TA: Combining Behavioral and Pharmacological Treatments for Obesity. Obesity Research. 2002, 10 (6): 560–574.PubMed
185.
Aronne LJ: Modern medical management of obesity: the role of pharmaceutical intervention. Journal of the American Dietetic Association. 1998, 98 (10): s23(4)-10.1016/S0002-8223(98)00706-8.
186.
Berke EM, Morden NE: Medical management of obesity. Am Fam Physician. 2000, 62 (2): 419–26.PubMed
187.
Moyers SB: Medications as adjunct therapy for weight loss: approved and off-label agents in use. J Am Diet Assoc. 2005, 105 (6): 948–59. 10.1016/j.jada.2005.03.010.PubMed
188.
O'Brien PE, Dixon JB, Brown W: Obesity is a surgical disease: overview of obesity and bariatric surgery. ANZ J Surg. 2004, 74 (4): 200–4. 10.1111/j.1445-2197.2004.03014.x.PubMed
189.
Steinbrook R: Surgery for severe obesity. N Engl J Med. 2004, 350 (11): 1075–9. 10.1056/NEJMp048029.PubMed
190.
Sugerman HJ: Bariatric surgery for severe obesity. J Assoc Acad Minor Phys. 2001, 12 (3): 129–36.PubMed
191.
Miller WC, Koceja DM, Hamilton EJ: A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention. Int J Obes Relat Metab Disord. 1997, 21 (10): 941–7. 10.1038/sj.ijo.0800499.PubMed
192.
Pikholz C, Swinburn B, Metcalf P: Under-reporting of energy intake in the 1997 National Nutrition Survey. N Z Med J. 2004, 117 (1202): U1079.PubMed
193.
Winkler J: The fundamental flaw in obesity research. Obesity Reviews. 2005, 6 (3):PubMed
194.
Klesges RC, Ward KD, Shelton ML: Changes in bone mineral content in male athletes. Mechanisms of action and intervention effects. Jama. 1996, 276 (3): 226–30. 10.1001/jama.276.3.226.PubMed
195.
Van Loan MD: Bioelectrical impedance analysis to determine fat-free mass, total body water and body fat. Sports Med. 1990, 10 (4): 205–17.PubMed
196.
197.
Antonio J, Stout J, eds: Sports Supplements. 2001, Lippincott Williams & Wilkins: Philadelphia, Pa, 1
198.
Smith NJ: Weight control in the athlete. Clin Sports Med. 1984, 3 (3): 693–704.PubMed
199.
Jonnalagadda SS, Skinner R, Moore L: Overweight athlete: fact or fiction?. Curr Sports Med Rep. 2004, 3 (4): 198–205. 10.1007/s11932-004-0016-y.PubMed
200.
Rankin JW: Weight loss and gain in athletes. Curr Sports Med Rep. 2002, 1 (4): 208–13. 10.1007/s11932-002-0023-9.PubMed
201.
Fogelholm M: Effects of bodyweight reduction on sports performance. Sports Med. 1994, 18 (4): 249–67.PubMed
202.
Kleiner S: Power Eating. 2001, Champaign, IL: Human Kinetics, 282–2
Metadata
Title
Obesity: Prevalence, Theories, Medical Consequences, Management, and Research Directions
Authors
Colin Wilborn
Jacqueline Beckham
Bill Campbell
Travis Harvey
Melyn Galbreath
Paul La Bounty
Erika Nassar
Jennifer Wismann
Richard Kreider
Publication date
01-12-2005
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1550-2783-2-2-4

Other articles of this Issue 2/2005

Journal of the International Society of Sports Nutrition 2/2005 Go to the issue

Research article

Effects of Coleus Forskohlii Supplementation on Body Composition and Hematological Profiles in Mildly Overweight Women

Commentary

Misconceptions about Aerobic and Anaerobic Energy Expenditure

Review

Dietary Supplements and Sports Performance: Amino Acids

Research article

Dietary Re-education, Exercise Program, Performance and Body Indexes Associated with Risk Factors in Overweight/Obese Women

Review

The Antioxidant Role of Glutathione and N-Acetyl-Cysteine Supplements and Exercise-Induced Oxidative Stress

Editorial

ISSN Roundtable: FAQs About the ISSN